Search

Author/Creator DeLozier, Amy M

1. 199 Baricitinib in patients with systemic lupus erythematosus: results from a phase 2, randomized, double-blind, placebo-controlled study. (April 2019)

Authors:
Silk, Maria E; Wallace, Daniel J; Furie, Richard A; Tanaka, Yoshiya; Kalunian, Kenneth C; Mosca, Marta; Petri, Michelle; Dörner, Thomas; Cardiel, Mario H; Bruce, Ian N; Gomez, Elisa; DeLozier, Amy M; Janes, Jonathan M; Linnik, Matthew D; Bono, Stephanie de; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 6(2019)supplement 1
Page Start:
A149
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Issue 10143 (21st July 2018)

Authors:
Wallace, Daniel J; Furie, Richard A; Tanaka, Yoshiya; Kalunian, Kenneth C; Mosca, Marta; Petri, Michelle A; Dörner, Thomas; Cardiel, Mario H; Bruce, Ian N; Gomez, Elisa; Carmack, Tara; DeLozier, Amy M; Janes, Jonathan M; Linnik, Matthew D; de Bono, Stephanie; Silk, Maria E; Hoffman, Robert W
Journal:
Lancet
Issue:
Volume 392:Issue 10143(2018)
Page Start:
222
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study. Issue 11 (10th August 2017)

Authors:
Keystone, Edward C; Taylor, Peter C; Tanaka, Yoshiya; Gaich, Carol; DeLozier, Amy M; Dudek, Anna; Zamora, Jorge Velasco; Cobos, Jose Arturo Covarrubias; Rooney, Terence; Bono, Stephanie de; Arora, Vipin; Linetzky, Bruno; Weinblatt, Michael E
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76:Issue 11(2017)
Page Start:
1853
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis. Issue 1 (21st March 2017)

Authors:
Emery, Paul; Blanco, Ricardo; Maldonado Cocco, Jose; Chen, Ying-Chou; Gaich, Carol L; DeLozier, Amy M; de Bono, Stephanie; Liu, Jiajun; Rooney, Terence; Chang, Cecile Hsiao-Chun; Dougados, Maxime
Journal:
RMD open
Issue:
Volume 3:Issue 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON). Issue 4 (31st October 2016)

Authors:
Smolen, Josef S; Kremer, Joel M; Gaich, Carol L; DeLozier, Amy M; Schlichting, Douglas E; Xie, Li; Stoykov, Ivaylo; Rooney, Terence; Bird, Paul; Sánchez Bursón, Juan Miguel; Genovese, Mark C; Combe, Bernard
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76:Issue 4(2017)
Page Start:
694
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗